Piper Sandler Lowers Prothena (NASDAQ:PRTA) Price Target to $81.00

Prothena (NASDAQ:PRTA – Get Free Report) had its target price cut by research analysts at Piper Sandler from $110.00 to $81.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on the company. HC […]

Leave a Reply

Your email address will not be published.

Previous post Cantor Fitzgerald Forecasts Strong Price Appreciation for Zscaler (NASDAQ:ZS) Stock
Next post Toy Stocks To Follow Now – May 27th